|9:50 AM - 10:15 AM||
FDA's Real-World Evidence Program
This session will cover the main elements of the framework for FDA’s real-world evidence program and will describe ongoing demonstration projects and collaborations. The emerging and evolving role of technological innovations in facilitating the use of real-world data will be discussed and highlighted. Examples of activities focused on the utilization of AI to support the development of therapeutics will be provided.